Answers are grounded in this paper and cite their sources.
Experimentally synthesized metal complexes show enhanced antimicrobial and anti-inflammatory activities, suggesting potential therapeutic uses.
Three new transition metal complexes, MnABPB, CoABPB, and NiABPB, were synthesized using the bidentate ligands Albendazole (AB) and 2‐(pyridin‐2‐yl)‐1H‐benzimidazole (PB) and thoroughly characterized. The complexes are air‐stable solids with high yields (80–85%) and thermal stability above 300 °C. Spectroscopic and analytical data confirm a 1:1:1 metal‐to‐ligand ratio. FT‐IR and UV‐Vis spectra, alongside magnetic moment measurements, reveal octahedral geometries for MnABPB and CoABPB, and a tetrahedral geometry for NiABPB. Molar conductivity distinguishes the ionic [Mn(AB)(PB)(H 2 O) 2 ]Cl 2 and [Ni(AB)(PB)]Cl 2 species from the neutral [Co(AB)(PB)(Cl) 2 ]. Density Functional Theory (DFT) calculations support the proposed geometries and provide deep insight into molecular reactivity. NiABPB exhibits the lowest HOMO energy (‐11.11 eV), highest electron affinity (8.46 eV), electronegativity (9.79 eV), and electrophilicity index (36.15 eV), along with the most negative chemical potential (‐9.79 eV), suggesting superior electron‐accepting ability and biological reactivity. Biological evaluations reveal substantial enhancement of antimicrobial and anti‐inflammatory activities upon complexation. Among the complexes, NiABPB displays the highest performance, with inhibition zone of (30 mm vs. E. coli ), strongest antifungal inhibition (20 mm vs. A. niger ), and the lowest anti‐inflammatory IC 50 value (45.02 µ M). Activity indices exceed 90% for all metal complexes, with NiABPB achieving 100% activity against E. coli . Molecular docking against DNA gyrase B (PDB ID: 4DUH) confirms strong binding affinities for all metal complexes, particularly NiABPB (‐8.10 kcal/mol) and MnABPB (‐8.20 kcal/mol), forming multiple hydrogen bonds (2.22–2.76 Å) with active site residues. These findings are consistent with the DFT reactivity descriptors and support the observed bioactivity trends.
No takes yet. Share an insight, caveat, or question.
Alkahtani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: